• KSBB Journal
• /
• 제18권1호
• /
• pp.74-77
• /
• 2003

대표적인 부패산물들로 잘 알려진 indole, skatole, 그리고 $\rho$-cresol 등을 측정하기 위한 방법으로 HPLC, spectrophotometric 법, 그리고 GC 및 GC/MSD 방법 등이 있으며, 수십년 간에 걸쳐 이러한 물질들의 분석이 이루어져 왔다. 본 연구에서는 많은 전처리 과정을 생략하여 분석물의 손실을 최소화하면서 GC 및 GC/MSD를 이용하여 쉽고 빠르게 측정할 수 있는 조건과 방법을 확립하였다. 측정사료는 건강한 성인 남녀의 분변이었으며, 내부 표준물질로 4-isopropylphenol을 사용하였으며, 분변 중 indole의 함량은 10~90 ppm 수준이었으며, skatole의 경우에는 약 40 ppm 정도로 검출되었다. 또한, $\rho$-cresol은 30~300 ppm 수준으로 그 분포 범위가 아주 넓게 나타났었다. GC/MSD를 이용하여 시료 중상기 물질들을 정성적으로 정확히 확인할 수 있었다. DB-17 capillary 컬럼을 이용하여 시료의 전처리 과정을 생략하여도 분석하려던 부패산물의 정성 및 정량에 방해되는 불순 peak는 없었고, 분리능도 매우 우수하였으므로 보다 빠르고 신속하게 상기 물질들을 확인할 수 있었다. 향후 본 연구를 통해 개발된 신속분석법이 분변에 존재하는 주요 부패산물들의 정량에 유용하게 사용되리라 판단된다.

• 한국식품영양학회지
• /
• 제11권5호
• /
• pp.488-492
• /
• 1998

This study was performed to investigate the influcence of various dietary fiber sources in Korea for activities of bacterial enzymes (${\beta}$-glucosidase, ${\beta}$-glucuronidase) and amounts of putrefactive product (indole) in aged rats. ${\beta}$-Glucosidase activity in the intestinal content was significantly lower in the seamustard 15% group than in other groups whereas the activity of ${\beta}$-glucuronidase was higher in the mugwort 15% group than other experimental groups. The amount of indole and pH in the intestinal content of aged rats were significantly lower in mugwort groups than in other groups.

• Journal of Microbiology and Biotechnology
• /
• 제12권4호
• /
• pp.657-663
• /
• 2002

Probiotics have been suggested to improve gastrointestinal health in humans. To investigate the effects of Bacillus polyfermenticus SCD administration on fecal microflora and putrefactive metabolites in humans, Bacillus polyfermenticus SCD (4.00${\times}$10$\sub$5/ CFU/mg) was administrated to ten healthy subjects (5 men and 5 women, average age 24 years) three times a day for 2 weeks. Fecal samples were collected before (1st and 2nd weeks, control), during (3rd and 4th weeks), and 2 weeks after the administration. The fo11owing microbial groups were evaluated in the feces: aerobic and anaerobic bacteria, Bacillus polyfermenticus SCD, Lactobacillus, Bifidobacterium, total lactic acid bacteria, Salmonella, Clostridium, Clostridium perfringens, Eubacterium, Staphylococcus, Coliform bacteria, Pseudomunas, and Yeast. Fecal concentrations of total aerobic bacteria (p<0.05, p<0.01, 3rd and 4th weeks), total lactic acid bacteria (p<0.01, 3rd, 4th and 5th weeks), and Bifidobacteria (p<0.05, 4th and 5th weeks) were significantly increased in all subjects, compared to the control, from the 3rd week after the administration of the products. Clostridium (p<0.01, 4th week), Clostridium perfringens (p<0.05, p<0.01, 3rd and 4th weeks), and coliform (p<0.01,5th week) were significantly reduced from the 3rd week of administration. No significant changes in the fecal concentrations of Pseudomonas, Lactobacillus, Eubacterium, Staphylococcus, yeast, and total anaerobes were observed. Six weeks after the administration, the concentration of all rnicroorganlsrns returned to the basal level. Bacillus polyfermenticus SCD was significantly maintained from the 3rd week to 6th week of the study. Despite the absence of a statistical significance, the putrefactive metabolites (ammonia, indole, skatole, and $\rho$-cresol) and the pH value tended to be lower during and after the test periods than the base line. These results show that this probiotic preparation is able to colonize the intestine, and suggest that it may be useful as a beneficial probiotic in humans.